| BioID | bio1996 |
| Name | DARIFENACIN |
| ChEMBL ID | CHEMBL1346 |
| Molecular Formula | C28H30N2O2 |
| Molecular Weight | 426.56 |
| Molecular Weight (Monoisotopic) | 426.2307 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | DARIFENACIN|DARIFENACIN EXTENDED RELEASE|DARIFENACINA|DARIFENACINE|UK-88525 |
| Smiles | NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1 |
| Inchi | InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1 |
| Inchi Key | HXGBXQDTNZMWGS-RUZDIDTESA-N |
| Molecular Species | BASE |
| Targets | 89.0 |
| Bioactivities | 199.0 |
| Np Likeness Score | -0.56 |
| Records Key | ['1', 'Darifenacin', 'Darifenacin', 'DARIFENACIN', 'Darifenacin', '3', 'Darifenacin', '3', '3', 'Darifenacin', 'SID50113277', 'LABA', 'Darifenacin', '2', 'darifenacin', 'Darifenacin', '3453', '4', 'Darifenacin', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'COVC-1211756174', 'darifenacin', 'BA1001186'] |
| Records Name | ['Indacaterol', '(S)-2-(1-(3-(2,3-dihydrobenzofuran-5-yl)propyl)pyrrolidin-3-yl)-2,2-diphenylacetamide', 'Darifenacin', 'DARIFENACIN', '2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide (Darifenacin)', '2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide', '2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide', 'Indacaterol', 'Indacaterol', 'Darifenacin', 'SID50113277', 'Indacaterol', 'Darifenacin', 'Darifenacin', 'darifenacin', 'Darifenacin', None, '(R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one', 'Darifenacin', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'DARIFENACIN', 'darifenacin', 'DARIFENACIN'] |
| Withdrawn Flag | False |
| Orphan | 0 |